TLR4 is a prominent factor in IBS pathophysiology, with research indicating that CRF–TLR4 proinflammatory cytokine signaling mediates gut barrier disruption and visceral hypersensitivity [52,53]. Here, CRH is linked to irritable bowel syndrome.